Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
Fuji
Julphar
US Department of Justice
AstraZeneca
Citi
Argus Health
Medtronic
Dow

Generated: January 18, 2018

DrugPatentWatch Database Preview

Insulin recombinant purified human; insulin susp isophane semisynthetic purified human - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for insulin recombinant purified human; insulin susp isophane semisynthetic purified human and what is the scope of insulin recombinant purified human; insulin susp isophane semisynthetic purified human freedom to operate?

Insulin recombinant purified human; insulin susp isophane semisynthetic purified human
is the generic ingredient in two branded drugs marketed by Bayer Pharms and Novo Nordisk Inc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for insulin recombinant purified human; insulin susp isophane semisynthetic purified human.
Summary for insulin recombinant purified human; insulin susp isophane semisynthetic purified human

US Patents and Regulatory Information for insulin recombinant purified human; insulin susp isophane semisynthetic purified human

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms MIXTARD HUMAN 70/30 insulin recombinant purified human; insulin susp isophane semisynthetic purified human INJECTABLE;INJECTION 019585-001 Mar 11, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NOVOLIN 70/30 insulin recombinant purified human; insulin susp isophane semisynthetic purified human INJECTABLE;INJECTION 019441-001 Jul 11, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Boehringer Ingelheim
QuintilesIMS
Moodys
Fuji
Citi
Chinese Patent Office
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot